Johnson & Johnson announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational study of icotrokinra, or JNJ-2113, the first targeted oral peptide that selectively blocks the ...
Yeah. We work very closely with JJDC. So JJDC stands for Johnson & Johnson Development Corporation. So this is the oldest health care VC in the industry. It's just marked 50 years. And we work very ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback